# Viability and Cardiac Resynchronization Therapy

> **NCT00955539** · NA · UNKNOWN · sponsor: **University Hospital, Gentofte, Copenhagen** · enrollment: 100 (estimated)

## Conditions studied

- Heart Failure
- Ischemic Cardiomyopathy

## Interventions

- **DEVICE:** AV-optimization followed by AV- and VV-optimization
- **DEVICE:** AV- and VV-optimization followed by AV-optimization only.

## Key facts

- **NCT ID:** NCT00955539
- **Lead sponsor:** University Hospital, Gentofte, Copenhagen
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-08
- **Primary completion:** 2012-12
- **Final completion:** 2013-06
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2011-10-06

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00955539

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00955539, "Viability and Cardiac Resynchronization Therapy". Retrieved via AI Analytics 2026-09-14 from https://api.ai-analytics.org/clinical/NCT00955539. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*